Mesenchymal Stem Cells in Tissue Repair
Top Cited Papers
Open Access
- 1 January 2013
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 4, 201
- https://doi.org/10.3389/fimmu.2013.00201
Abstract
The advent of mesenchymal stem cell (MSC) based therapies for clinical therapeutics has been an exciting and new innovation for the treatment of a variety of diseases associated with inflammation, tissue damage and subsequent regeneration and repair. Application-based ability to measure MSC potency and fate of the cells post-MSC therapy are the variables that confound the use of MSCs therapeutics in human diseases. An evaluation of MSC function and applications with attention to detail in the preparation as well as quality control (QC) and quality assurance (QA) are only as good as the assays that are developed. In vivo measures of efficacy and potency require an appreciation of the overall pathophysiology of the model and standardization of outcome measures. The new concepts of how MSC’s participate in the tissue regeneration and wound repair process and further, how this is impacted by estimates of efficacy and potency Are important new topics. In this regard,,, this chapter will review some of the in vitro and in vivo assays for MSC function and activity and their application to the clinical arena.Keywords
This publication has 82 references indexed in Scilit:
- Micromarrows—Three-Dimensional Coculture of Hematopoietic Stem Cells and Mesenchymal Stromal CellsTissue Engineering, Part C: Methods, 2012
- [Current research advance on abnormalities of mesenchymal stem cells in hematological malignancies].2011
- Advances and challenges in translating stem cell therapies for clinical diseasesTranslational Research, 2010
- Cotransplantation of Mesenchymal Stem Cells Might Prevent Death from Graft-versus-Host Disease (GVHD) without Abrogating Graft-versus-Tumor Effects after HLA-Mismatched Allogeneic Transplantation following Nonmyeloablative ConditioningTransplantation and Cellular Therapy, 2010
- Defining human mesenchymal stem cell efficacy in vivoJournal of Inflammation, 2010
- Why are MSCs therapeutic? New data: new insightThe Journal of Pathology, 2008
- Immunological properties of mesenchymal stem cells and clinical implicationsArchivum Immunologiae et Therapiae Experimentalis, 2008
- Points to Consider in Designing Mesenchymal Stem Cell-Based Clinical TrialsTransfusion Medicine and Hemotherapy, 2008
- Bone Marrow-derived Mesenchymal Stem Cells Decrease Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cells TransplantationImmunological Investigations, 2008
- Mesenchymal stem cells: characteristics and clinical applications.2006